Cantourage was founded in 2020 with a clear mandate: to build the infrastructure the UK medical cannabis market was missing. Reliable supply, transparent sourcing, and clinical rigour; these are not differentiators for us. They are the baseline.
Since the UK legalised medical cannabis in 2018, access has remained challenging. Complex regulations, fragmented supply chains, and inconsistent product quality have left pharmacies unable to fulfil prescriptions and patients without medication. We exist to help change that.
Our relationship with Cantourage SE, a Frankfurt Stock Exchange listed business, takes that mission further. It gives us access to a wider European platform, deeper supplier relationships, proven import pathways, and broader market intelligence, helping us operate with more confidence in a fast-moving category.
Today, Cantourage operates as a full-stack supply partner, connecting tier-1 cultivators in Europe, Canada, and New Zealand to pharmacies and clinics across the United Kingdom.